Adjuvant Capecitabine combined with Toripalimab or Capecitabine only in R0 resected Intrahepatic Cholangiocarcinoma: an open randomised, controlled study
Latest Information Update: 30 Nov 2020
At a glance
- Drugs Capecitabine (Primary) ; Toripalimab (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 30 Nov 2020 New trial record